M16411
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Myerowitz R, Hogikyan ND. Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease. Science 232: 1646-1648, 1986. PubMed: 3754980
Myerowitz R, et al. Human beta-hexosaminidase alpha chain: Coding sequence and homology with the beta chain. Proc. Natl. Acad. Sci. USA 82: 7830-7834, 1985. PubMed: 2933746
Nakai H, et al. Assignment of beta-hexosaminidase A alpha-subunit to human chromosomal region 15q24----q24. Cytogenet. Cell Genet. 56: 164, 1991. PubMed: 1829032
Myerowitz R. Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group. Proc. Natl. Acad. Sci. USA 85: 3955-3959, 1988. PubMed: 3375249
Barbara Weiffenbach, personal communication
